MicroRNA-34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma

Figure 7

Association of immunohistochemistry markers with the clinicopathological features in RCC patients. The figures illustrated higher intensity of Ki67, TGFB1, VEGFA, and Tp53 in RCC tumors with advanced pathological grade (a–d), extensive staining of Ki67 antibodies in T3 samples and capsular infiltration (e-f), and differential expression of Tp53 and TGFB1 in various histopathological subtypes (g-h).

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)